160 related articles for article (PubMed ID: 18469795)
1. WT1 immunoreactivity in breast carcinoma: selective expression in pure and mixed mucinous subtypes.
Domfeh AB; Carley AL; Striebel JM; Karabakhtsian RG; Florea AV; McManus K; Beriwal S; Bhargava R
Mod Pathol; 2008 Oct; 21(10):1217-23. PubMed ID: 18469795
[TBL] [Abstract][Full Text] [Related]
2. The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast.
Lee AH; Paish EC; Marchio C; Sapino A; Schmitt FC; Ellis IO; Reis-Filho JS
Histopathology; 2007 Dec; 51(6):824-8. PubMed ID: 18042071
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic features of micropapillary variant of pure mucinous carcinoma of breast].
Lin HY; Gao LX; Jin ML; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):613-7. PubMed ID: 23157830
[TBL] [Abstract][Full Text] [Related]
4. Correlation between solid papillary carcinoma and associated invasive carcinoma according to expression of WT1 and several MUCs.
Oh EJ; Koo JS; Kim JY; Jung WH
Pathol Res Pract; 2014 Dec; 210(12):953-8. PubMed ID: 25204785
[TBL] [Abstract][Full Text] [Related]
5. Mucinous micropapillary carcinoma of the breast: an aggressive counterpart to conventional pure mucinous tumors.
Barbashina V; Corben AD; Akram M; Vallejo C; Tan LK
Hum Pathol; 2013 Aug; 44(8):1577-85. PubMed ID: 23517923
[TBL] [Abstract][Full Text] [Related]
6. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
[TBL] [Abstract][Full Text] [Related]
7. Micropapillary variant of mucinous carcinoma of the breast shows genetic alterations intermediate between those of mucinous carcinoma and micropapillary carcinoma.
Pareja F; Selenica P; Brown DN; Sebastiao APM; da Silva EM; Da Cruz Paula A; Del A; Fu L; Weigelt B; Brogi E; Reis-Filho JS; Wen HY
Histopathology; 2019 Jul; 75(1):139-145. PubMed ID: 30843622
[TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine differentiation and Wilms' tumor protein-1 expression in breast mucinous carcinoma and their significance].
Wang J; Weng S; Jin X; Yu W; Zhou T; Gan M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):45-50. PubMed ID: 27045240
[TBL] [Abstract][Full Text] [Related]
9. Cytologic findings in infiltrating micropapillary carcinoma and mucinous carcinomas with micropapillary pattern.
Madur B; Shet T; Chinoy R
Acta Cytol; 2007; 51(1):25-32. PubMed ID: 17328491
[TBL] [Abstract][Full Text] [Related]
10. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.
Lacroix-Triki M; Suarez PH; MacKay A; Lambros MB; Natrajan R; Savage K; Geyer FC; Weigelt B; Ashworth A; Reis-Filho JS
J Pathol; 2010 Nov; 222(3):282-98. PubMed ID: 20815046
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of mixed histological subtypes in invasive breast carcinoma: a retrospective analysis.
Rechsteiner A; Dietrich D; Varga Z
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4967-4978. PubMed ID: 36310301
[TBL] [Abstract][Full Text] [Related]
13. Presence of a micropapillary pattern in mucinous carcinomas of the breast and its impact on the clinical behavior.
Shet T; Chinoy R
Breast J; 2008; 14(5):412-20. PubMed ID: 18673338
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of WT1 expression in invasive breast carcinoma with >90% mucinous component.
Xu X; Bi R; Shui R; Yu B; Cheng Y; Tu X; Yang W
J Clin Pathol; 2022 Dec; 75(12):832-836. PubMed ID: 34244341
[TBL] [Abstract][Full Text] [Related]
15. WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium.
Acs G; Pasha T; Zhang PJ
Int J Gynecol Pathol; 2004 Apr; 23(2):110-8. PubMed ID: 15084838
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of micropapillary pattern in pure mucinous carcinoma of the breast.
Bal A; Joshi K; Sharma SC; Das A; Verma A; Wig JD
Int J Surg Pathol; 2008 Jul; 16(3):251-6. PubMed ID: 18387988
[TBL] [Abstract][Full Text] [Related]
17. PAX 2: a novel Müllerian marker for serous papillary carcinomas to differentiate from micropapillary breast carcinoma.
Chivukula M; Dabbs DJ; O'Connor S; Bhargava R
Int J Gynecol Pathol; 2009 Nov; 28(6):570-8. PubMed ID: 19851209
[TBL] [Abstract][Full Text] [Related]
18. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.
Nonaka D; Chiriboga L; Soslow RA
Am J Surg Pathol; 2008 Oct; 32(10):1566-71. PubMed ID: 18724243
[TBL] [Abstract][Full Text] [Related]
19. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features.
Ramalingam P; Middleton LP; Tamboli P; Troncoso P; Silva EG; Ayala AG
Ann Diagn Pathol; 2003 Apr; 7(2):112-9. PubMed ID: 12715337
[TBL] [Abstract][Full Text] [Related]
20. Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components.
Marchiò C; Iravani M; Natrajan R; Lambros MB; Geyer FC; Savage K; Parry S; Tamber N; Fenwick K; Mackay A; Schmitt FC; Bussolati G; Ellis I; Ashworth A; Sapino A; Reis-Filho JS
J Pathol; 2009 Jul; 218(3):301-15. PubMed ID: 19479727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
